Immunology Advance: How An Immune Molecule Initiates Liver Fibrosis
Channel: NIAID
Date: 12/07/2016

NIAID research fellow Trey Gieseck, Ph.D., describes results from a mouse study showing how an immune signaling molecule called interleukin-13 initiates liver fibrosis (scarring) from a common parasitic infection. The research lends support to experimental treatments that aim to block interleukin-13 to slow or prevent liver fibrosis.